Experimental Therapy of Breast Cancer with Anti-breast Epithelial Radioimmunoconjugates
Therapy of breast cancer with monoclonal antibodies (MoAbs) conjugated or unconjugated faces serious challenges not only for researchers to obtain MoAbs adequate to bring the desired conjugate to the tumors and spare other organs, but also to create MoAbs that could act in an unconjugated form. Of the latter type, those that will participate in antibody dependent cell mediated and complement dependent cytotoxicity are desired.
KeywordsCellulose Toxicity HPLC Cage Adenocarcinoma
Unable to display preview. Download preview PDF.
- 1.M. Sasaki, J.A. Peterson, and R.L. Ceriani. Monoclonal antibodies against breast epithelial cell surface antigens in breast cancer therapy. Hybridoma, 2:120 (1983).Google Scholar
- 3.G.C. Buehring. Effect of hormones and chemicals on expression of milk fat globule antigens by breast cell line MCF-7. In Vitro, 22:50A (1986).Google Scholar
- 10.K.M. Hwang, E.W. Blank, and R.L. Ceriani. Experimental immunotherapy of human breast tumors with conjugated and unconjugated monoclonal antibodies. 8th Annual San Antonio Breast Cancer Symp., Nov. (1985).Google Scholar